双耳炎抗毒素生产和采购实践和挑战
Emerging infectious diseases
|January 6, 2026
概括
马耳白抗毒素 (DAT) 的可用性和定价不一致,这给全球疫情应对带来了挑战. 财政障碍也阻碍了替代单克隆抗体治疗喉的发展.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 公共卫生准备情况 公共卫生准备情况
背景情况:
- 呼吸道角膜炎的治疗需要迅速的马角膜炎抗毒素 (DAT) 给药,以中和循环中的毒素.
- 全球喉疫情引发了持续的公共卫生挑战.
研究的目的:
- 评估当前的市场动态,包括价格和可用性,马耳白抗毒素 (DAT).
- 为制造商和采购机构确定预测DAT需求的挑战.
- 探索单克隆抗体开发人员面临的进展和财务障碍,作为潜在的替代方案.
主要方法:
- 与参与DAT生产或采购的关键采购机构和制造商进行调查.
- 与单克隆抗体疗法的开发者进行了关键告密者采访.
主要成果:
- 马角膜炎抗毒素 (DAT) 的价格和可用性表现出显著的变化.
- 对DAT的准确需求预测对制造商和采购实体来说都是一个挑战.
- 人们对DAT供应不足存在担忧,以应对不断升级的全球白喉疫情.
- 单克隆抗体开发人员报告说,财政限制阻碍了临床和制造业的进步.
结论:
- 目前的马喉抗毒素 (DAT) 供应链在满足全球需求方面面临重大挑战.
- 金融不稳定性对开发和扩大单克隆抗体等替代性耳喉治疗的发展和扩展构成了障碍.
- 改进的预测和制造策略对于确保在疫情爆发期间提供足够的DAT至关重要.
更多相关视频
相关概念视频
Vaccine Production
152
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
152
Diphtheria
187
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
187


